SEC Form 4 · accession 0001209191-16-136712
MARRONE BIO INNOVATIONS INC · MBII
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
James Boyd
Officer — Chief Financial Officer
Period of report
Aug 11, 2016
Accepted (ET)
Aug 11, 2016 · 9:39 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001441693
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 11, 2016 | A | 31,250 | $0.00 | A | 46,250 | D |
Table II — derivative securities
No Table II lines on this filing.